Arkolith/Insider Trading/GENB/Form 4

Grous Beth

Chief People OfficerGenerate Biomedicines, Inc. (GENB) · full profile →Form 4 · filed Mar 2, 2026
Net Buying
Open-Market Buys
$5K
Open-Market Sells
$0
Net Open-Market Flow
$5K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Buy(P)300$16.00$5K300

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 26, 2026Grant(A)114K—$0114K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-085939) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML